title: Chemotherapy, cognitive impairment and hippocampal toxicity.
abstract: Cancer therapies can be associated with significant central nervous system (CNS) toxicity. While radiation-induced brain damage has been long recognized both in pediatric and adult cancer patients, CNS toxicity from chemotherapy has only recently been acknowledged. Clinical studies suggest that the most frequent neurotoxic adverse effects associated with chemotherapy include memory and learning deficits, alterations of attention, concentration, processing speed and executive function. Preclinical studies have started to shed light on how chemotherapy targets the CNS both on cellular and molecular levels to disrupt neural function and brain plasticity. Potential mechanisms include direct cellular toxicity, alterations in cellular metabolism, oxidative stress, and induction of pro-inflammatory processes with subsequent disruption of normal cellular and neurological function. Damage to neural progenitor cell populations within germinal zones of the adult CNS has been identified as one of the key mechanisms by which chemotherapy might exert long-lasting and progressive neurotoxic effects. Based on the important role of the hippocampus for maintenance of brain plasticity throughout life, several experimental studies have focused on the study of chemotherapy effects on hippocampal neurogenesis and associated learning and memory. An increasing body of literature from both animal studies and neuroimaging studies in cancer patients suggests a possible relationship between chemotherapy induced hippocampal damage and the spectrum of neurocognitive deficits and mood alterations observed in cancer patients. This review aims to briefly summarize current preclinical and neuroimaging studies that are providing a potential link between the neurotoxic effects of chemotherapy and hippocampal dysfunction, highlighting challenges and future directions in this field of investigation.
authors.affiliation: Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: Dietrich.Jorg@mgh.harvard.edu.
authors.forename: J
authors.initials: J
authors.lastname: Dietrich
authors.affiliation: Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Prust
authors.affiliation: Institute of Medical Psychology, Medical Faculty, Goethe University, Heinrich-Hoffmann-Str. 10, 60528 Frankfurt am Main, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Kaiser
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D003072:Cognition Disorders / Q000139:chemically induced* / Q000473:pathology; D006624:Hippocampus / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D008568:Memory / Q000187:drug effects; D055495:Neurogenesis / Q000187:drug effects; D009929:Organ Size
chemical_list: D000970:Antineoplastic Agents
keywords: chemotherapy; cognitive dysfunction; hippocampus; neural progenitor cells; neurotoxicity